Discover 1 curated intelligence briefings related to this specific topic.
July 2026 marks a volatile inflection point for medical delivery. New data from the AAIC and Phase 1b trials reveal a surge in lipid transport modulation and high-efficiency retinal delivery, while crowdfunding disrupts the financial pipeline of gene therapy.
